between PCBs, breast cancer
In the largest such study to date funded by the National Cancer Institute and the National Institute of Environmental Health and Safety, researchers at the Yale Cancer Center did not find a significant relationship between exposure to PCBs or the pesticide DDE, and the risk of breast cancer in women.
In a case-control study of nearly 1,000 Connecticut women, blood serum levels of polychlorinated biphenyls (PCBs) and the organochloride compound DDE were analyzed for an association with breast cancer risk. No significant difference in serum levels was found between the women with breast cancer and the control group.
"I am hopeful that this, our most recent and conclusive study, will put to rest the notion that exposure to DDE causes breast cancer," said Tongzhang Zheng, associate professor of epidemiology and public health and the lead author of the study. "Based on these results, it is also unlikely that total PCBs have a major impact on the risk of breast cancer," he adds.
The question of whether environmental exposure to organochloride compounds (particularly PCBs and DDE) increases the risk of female breast cancer has been debated in recent years, but studies relating PCBs and DDE to breast cancer have produced inconclusive results. Many of the earlier studies, however, were based on a relatively small number of study subjects, and were not designed to take into account potentially important factors that might modify the relationship between PCB and DDE exposures and development of breast cancer.
In this most recent study, a total of 475 breast cancer patients who either had breast-related surgery at Yale-New Haven Hospital (Y-NHH) or were residents of Tolland County (which has similar breast cancer incidence and mortality rates to New Haven County) comprised the group of cases. The control group of 502 women without breast cancer was randomly selected from among women who had normal tissue or newly diagnosed benign breast disease or normal tissue at Y-NHH or from Tolland County residents.
Zheng and colleagues have also examined the levels of the chemical compounds DDT, DDE, hexachlorobenzene (HCB) or benzene hexachloride (BHC), oxychlordane and trans-nonachlor in the breast adipose tissue of women with and without breast cancer. No significant difference was found in the levels of these compounds between breast cancer cases and their matched controls.
Other Yale Cancer Center members collaborating on these research projects include Theodore Holford, Susan T. Mayne, Dr. Barbara Ward and Dr. Darryl Carter. Other investigators from the School of Medicine, including Patricia Owens and Dr. Robert Dubrow, also participated in the study.
T H I S
Bulletin Home
W E E K ' SS T O R I E S
Student and Alumni receive noted awards
YSN scientist still uncovering Agent Orange's harmful effects
Book traces 'unsteady march' to racial equality
Endowed Professorships
Mullinix will take on new challenges as V.P. of the University of California
Grant to expand nurse's program for diabetic teens
Professors' model helps predict March Madness victors
Most Vietnam veterans were exposed to toxic Agent Orange, Yale scientist testifies
Joseph Goldstein, noted for his work in family law, dies
Exhibit celebrates 30 years of women artists at Yale
'Father and Sons' exhibit features works by three family members
Visual Journals' on view in Medical Library
CONFERENCES ON CAMPUS
Census count will be held on campus April 3-6
Faculty share 'experience' with students at teas
EPH seminar to examine impact of domestic violence on individuals, community
Labor conditions in developing nations will be focus of YCIAS roundtable
Yale researchers find no relation between PCBs, breast cancer
Liman Fellow Sager to discuss her work with 'All Our Kin'
Ovarian cancer is topic of forums
Yale authors will talk about their books
Yale Scoreboard
In the News
|Visiting on Campus|
Calendar of Events|Bulletin Board
Classified Ads|Search Archives|Production Schedule|Bulletin Staff
Public Affairs Home|News Releases|
E-Mail Us|Yale Home Page